On May 25, 2026, Pope Leo XIV released his first encyclical, “Magnifica humanitas: On Safeguarding the Human Person in the…
Read More →
The SuperReturn juggernaut landed back in Berlin last week, once again serving as the private markets industry’s pre-eminent gathering point.…
Read More →
Getting hit by a car while you’re walking in a crosswalk is one of the most shocking and physically painful…
Read More →
On June 4, 2026, Texas Attorney General (AG) Ken Paxton announced an investigation into Celsius Holdings, Inc. (Celsius) regarding the…
Read More →
In the June edition of For Your Consumption, our food & beverage digest of court cases and litigation trends affecting…
Read More →
Michael Volkov analyzes the Commerce Department Bureau of Industry and Security’s June 12, 2026 export control directive ordering Anthropic to…
Read More →
In recent weeks, Congress and the Administration have escalated scrutiny of China-linked biotechnology, pharmaceutical development, and related intellectual property. The…
Read More →
In a unanimous decision of June 4, 2026 in Hikma Pharmaceutical USA Inc. v. Amarin Pharma Inc., authored by Justice…
Read More →
In the recent ruling in Hikma Pharmaceuticals v. Amarin Pharma, No. 24–889., the U.S. Supreme Court applied its pleading standards…
Read More →
Our Patent Case Summaries provide a weekly summary of the precedential patent-related opinions issued by the Court of Appeals for…
Read More →